10.1016/0223-5234(92)90148-T
The research focuses on the synthesis and antihepatotoxicity evaluation of Wuweizisu analogues. The purpose of the study is to develop new liver-protective agents by synthesizing and testing the efficacy of certain chemical compounds derived from Schisandra sinensis (Wuweizi), a traditional Chinese medicine known for its various pharmacological properties, especially its antihepatotoxic effects. The researchers synthesized a series of compounds, including dimethyl 4,4’-dimethoxy-5,6,5’,6’-dimethylenedioxybiphenyl-2,2’-dicarboxylate (VII) and 6-phenyl-3,9-dimethoxy-1,2-methylenedioxy-10,11-methylenedioxy-6,7-dihydro-5H-dibenz(c,e)azepin (X), using key chemicals such as gallic acid, dimethyl sulfate, bromine, aniline, and lithium aluminum hydride. The synthesized compounds were tested for their ability to protect against carbon tetrachloride-induced liver damage in primary cultured rat hepatocytes. The results showed that compound X exhibited superior antihepatotoxic activity compared to the known protective agents DDB and silymarin. This suggests that the synthesized compounds, particularly those with a dibenzoazepin structure, could serve as potential new liver-protective agents, offering a novel route for the development of such pharmaceuticals.